If you wish to download the documents, please click on the links below:
Current EAMBES Governance and the past Executives of EAMBES.
The European Medicines Agency (EMA), has released for public consultation, a draft policy on the publication and access to clinical trial data.
The draft policy aims to take into account the different views and concerns brought forward by a broad range of stakeholders and European bodies, balancing out the commitment to give widest possible access to data for independent scrutiny with the need to protect personal data as well as legitimate commercially confidential information. It includes three categories of clinical-trial data corresponding to different levels of access:
Comments must be sent not later than 30 September to [email protected] The Draft policy on the publication and access to clinical-trial data is available here.